Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,147
Closed -$226K 774
2025
Q4
$226K Sell
2,147
-13,671
-86% -$1.28M 0.02% 487
2025
Q3
$1.33M Buy
+15,818
New +$1.3M 0.1% 216
2024
Q3
Sell
-7,820
Closed -$968K 554
2024
Q2
$968K Sell
7,820
-5,969
-43% -$769K 0.1% 254
2024
Q1
$1.82M Buy
+13,789
New +$1.7M 0.23% 151
2021
Q4
Sell
-2,926
Closed -$220K 357
2021
Q3
$220K Buy
+2,926
New +$223K 0.02% 275
2020
Q4
Sell
-7,644
Closed -$605K 499
2020
Q3
$605K Buy
+7,644
New +$599K 0.06% 241

Other funds holding MRK

Atom Investors's MRK Position: Q1 2026 in Review

Atom Investors sold out of Merck (MRK) in Q1 2026, closing a stake of 2,147 shares — an estimated $226K sold.

Atom Investors first reported a position in MRK in Q3 2020 and held it in 6 quarters. The position peaked at $1.82M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Atom Investors reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 2,147 Merck shares in Q1 2026, an estimated $226K.
  • Atom Investors first reported a position in Merck in Q3 2020 and held it in 6 quarters.
  • Atom Investors's Merck position peaked at $1.82M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.